1.	Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 0 to 21 Sponsor: NCI, Other Protocol IDs: CDR0000064664, POG-9404, NCT01230983
2.	Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Disease Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 21 and under Sponsor: NCI, Other Protocol IDs: CDR0000065013, POG-9426, CCG-P9426, NCT00002827
3.	Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 21 and under Sponsor: NCI, Other Protocol IDs: CDR0000065359, COG-9425, POG-9425, NCT00005578
4.	Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 8 to 120 Sponsor: NCI, Other Protocol IDs: CDR0000065745, POG-9480, NCI-P97-0086, NCT00003070
5.	Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 1 to 17 Sponsor: NCI, Other Protocol IDs: CDR0000066202, DFCI-95001, DFCI-FDR001197, NCI-G99-1651, NCT00004034
6.	Paclitaxel With or Without Trastuzumab in Treating Patients With or Without HER-2/Neu Breast Cancer That is Inoperable, Recurrent, or Metastatic Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-02792, CALGB-9840, U10CA031946, CDR0000066468, CLB-9840, NCT00003440
7.	Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 30 and under Sponsor: NCI, Other Protocol IDs: CDR0000067129, COG-P9754, POG-P9754, CCG-P9754, P9754, NCT00003937
8.	Phase III Pilot Randomized Study of Filgrastim-SD/01 Versus Filgrastim (G-CSF) With Concurrent Chemotherapy in Patients With Newly Diagnosed Sarcoma (Closed to Accrual as of 5/26/2009) Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 25 and under at diagnosis Sponsor: NCI Protocol IDs: NCI-00-C-0092, AMGEN-20000124, NCT00020137
9.	Phase III Randomized Trial of FAC (5-FU/ADR/CTX) with vs without ICRF-187 for Cardioprotection in Patients with Advanced Breast Cancer Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: DUT-BR-1, NCI-T85-0009Q, T85-0009
10.	Phase III Comparison of Standard-Dose CACP vs High-Dose CACP in Hypertonic NaCl vs High-Dose CACP/MITO in Patients with Metastatic non-Small Cell Lung Cancer (Summary Last Modified 07/97) Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: any age Sponsor: NCI Protocol IDs: SWOG-8738
11.	Phase III Randomized Study of ICRF-187 Cardioprotection in Patients Treated with ADR for Pediatric Sarcomas Phase: Phase III Type: Supportive care Status: Completed Age: 25 and under Sponsor: NCI Protocol IDs: NCI-89-C-07, NCI-T88-0200N, T88-0200
12.	Phase III Study of High-Dose CTX plus GM-CSF with vs without WR-2721 Chemoprotection in Patients with Advanced Malignancies Phase: Phase III Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-9160, CALGB-9160
13.	SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease Phase: Phase III Type: Supportive care, Treatment Status: Closed Age: 16 and over Sponsor: NCI, Other Protocol IDs: CDR0000077691, U10CA032102, SWOG-9133, CLB-9391, NCT00002495
14.	Phase II Study of High-Dose Doxorubicin with Dexrazoxane Cardioprotection and GM-CSF for Advanced Malignant Mesothelioma (Summary Last Modified 09/97) Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: any age Sponsor: NCI Protocol IDs: CLB-9631, CALGB-9631
15.	Phase II Study of Neoadjuvant Cisplatin, Methotrexate, and Doxorubicin Plus Dexrazoxane Followed By Surgery and Adjuvant Cisplatin, Methotrexate, Doxorubicin, and Dexrazoxane in Patients With Osteosarcoma Phase: Phase II Type: Supportive care, Treatment Status: Closed Age: 25 and under Sponsor: NCI Protocol IDs: NCI-99-C-0125I, NCT00019864
16.	Phase II Study of Induction with VAdriaC (VCR/DOX/CTX) and Consolidation with MIME (L-PAM/IFF/VP-16) with PBSC/G-CSF Support for Patients with Ewing's Sarcoma, Rhabdomyosarcoma, and Neuroblastoma, with a Phase II Window Evaluating Initial TOPO in High-Risk Patients Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 1 to 25 Sponsor: NCI Protocol IDs: NCI-93-C-0125H, NCI-T92-0226N, T92-0226
17.	Phase I Study of Paclitaxel plus Doxorubicin/Dexrazoxane with and without Growth Factor Support in Women with Advanced Breast Cancer (Summary Last Modified 04/2000) Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: any age Sponsor: NCI Protocol IDs: AECM-119951142, NCI-T95-0054O, T95-0054
18.	Oblimersen Plus Combination Chemotherapy and Dexrazoxane in Treating Children and Adolescents With Relapsed or Refractory Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 1 to 21 Sponsor: NCI Protocol IDs: NCI-2012-01872, ADVL0211, U01CA097452, CDR0000069387, COG-ADVL0211, NCI-03-C-0202, NCT00039481
19.	Phase I Study of ICRF-187 Pretreatment for Protection Against Doxorubicin Cardiotoxicity Phase: Phase I Type: Supportive care Status: Closed Age: no age specified Sponsor: NCI Protocol IDs: OSU-83HO096, NCI-T83-1050W
20.	Phase I Study of Doxorubicin with ICRF-187 Cardioprotection plus GM-CSF in Patients with Advanced Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: NYU-T89-0049, NCI-T89-0049D, T89-0049
21.	Phase I Trial of High-Dose DOX plus Recombinant GM-CSF plus ADR-529 in Patients with Solid Tumors Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CLB-8983, CALGB-8983
22.	Phase I Pilot Study of High-Dose DOX Given with G-CSF and ADR-529 in the Adjuvant Treatment of Patients with Hepatocellular Carcinoma Who Have Undergone Hepatectomy and Orthotopic Liver Transplantation Phase: Phase I Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MTS-91414-NPD, NCI-T91-0234O, T91-0234
23.	Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer Phase: Phase I Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CCCWFU 98509, NCI-2010-00125, NCT01051401
24.	SWOG-9342 Chemotherapy in Treating Women Enrolled in the SWOG-8897 Clinical Trial Phase: No phase specified Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000065237, U10CA032102, SWOG-9342, NCT00002900
25.	Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant Phase: No phase specified Type: Supportive care Status: Completed Age: 11 and over Sponsor: NCI, Other Protocol IDs: IR 7141, P30CA077598, UMN-2003NT063, CDR0000642276, IR-6980, FHCRC-2357.00, 2003NT063, NCT00920842